Brian Henry
Impact in
-
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
-
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- RNA Interference and Gene Delivery
- Protein Kinase Regulation and GTPase Signaling
Papers in
-
- Ubiquitin and proteasome pathways 4
- Protein Degradation and Inhibitors 3
- Chemical Synthesis and Analysis 1
- Oncology 4
- Peptidase Inhibition and Analysis 3
- Cancer-related Molecular Pathways 1
- Co-authors
- Anthony W. Partridge (5 shared papers)Simon Ng (5 shared papers)Shuhui Lim (4 shared papers)Shih Chieh Chang (3 shared papers)David P. Lane (1 shared paper)Christopher J. Brown (1 shared paper)Greg L. Beilhartz (1 shared paper)Charles W. Johannes (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (1 paper)Scientific Reports (1 paper)Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)ACS Central Science (1 paper)
- Partner nations
- United StatesCanadaSingapore
In The Last Decade
Brian Henry
6 papers receiving 212 citations
Peers
Comparison fields: 5 of 39
- Oncology 90
- Molecular Biology 192
- Hematology 21
- Immunology 22
- Radiology, Nuclear Medicine and Imaging 24
Countries citing papers authored by Brian Henry
This map shows the geographic impact of Brian Henry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Henry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Henry more than expected).
Fields of papers citing papers by Brian Henry
This network shows the impact of papers produced by Brian Henry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Henry. The network helps show where Brian Henry may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian Henry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 107 | |
| 2 | 2020 | 55 | |
| 3 | 2008 | 20 | |
| 4 | 2022 | 19 | |
| 5 | 2022 | 10 | |
| 6 | 2022 | 4 |
About Brian Henry
Brian Henry is a scholar working on Molecular Biology, Oncology, Hematology, Immunology and Allergy and Immunology, having authored 6 papers that have together received 215 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (4 papers), Peptidase Inhibition and Analysis (3 papers), Protein Degradation and Inhibitors (3 papers), Cancer-related Molecular Pathways (1 paper), T-cell and B-cell Immunology (1 paper), Multiple Myeloma Research and Treatments (1 paper), Chemical Synthesis and Analysis (1 paper) and Immune Cell Function and Interaction (1 paper). The work is most often cited by research in Oncology (90 citations), Molecular Biology (192 citations), Hematology (21 citations), Immunology (22 citations) and Radiology, Nuclear Medicine and Imaging (24 citations). Brian Henry has collaborated with scholars based in United States, Canada and Singapore. Frequent co-authors include Anthony W. Partridge, Simon Ng, Shuhui Lim, Shih Chieh Chang, David P. Lane, Christopher J. Brown, Greg L. Beilhartz, Charles W. Johannes, Roman A. Melnyk and Pooja Gopal. Their work appears in journals such as Journal of Medicinal Chemistry, Scientific Reports, Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and ACS Central Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.